Article
Short-Term Renal Effects of Add-On Levetiracetam in Client-Owned Dogs with Idiopathic Epilepsy Receiving Phenobarbital: A Four-Week Prospective Study
2026-07-29
Abstract excerpt
Levetiracetam (LEV) is a commonly used adjunctive antiseizure medication (ASM) in dogs because of its favorable pharmacokinetic profile and limited hepatic metabolism. However, because LEV is predominantly eliminated through renal excretion, prospective clinical evidence regarding its effects on renal function in dogs remains limited. This prospective study evaluated short-term changes in renal biomarkers during a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4db5290f-c870-5d3b-b7ea-6cc1ad724ef4
- DOI
- 10.20944/preprints202607.2130.v1
